The size of the Dialysis Equipment market in the Middle East & Africa is expected to grow USD 2.54 billion by 2026 from USD 2.12 billion in 2021, registering a CAGR of 3.7% during the forecast period.
The dialysis devices and devices market include the sale of dialysis devices and equipment and related services by entities (organizations, sole proprietorships, and partnerships) that manufacture dialysis devices and equipment used in the treatment of dialysis patients. . . The dialysis equipment and devices industry include establishments that manufacture dialysis equipment and devices such as dialyzers and dialysis pumps and other instruments used in the dialysis process, including blood pumps, dialysis machines, dialysis machines, catheters, and tube kits.
New financing channels in healthcare, improving healthcare infrastructure, a growing number of dialysis patients who need dialysis, and the adoption of advanced technologies in dialysis equipment are some of the factors that are expected to drive the MEA dialysis equipment market. As a result, the Middle East and Africa continue to compete with renal dialysis equipment at a high growth rate.
Current dialysis methods place a heavy burden on a country's health system and change the patient's lifestyle. Therefore, dialysis patients must adapt their lifestyle and routine to the treatment program. Therefore, research is underway to develop a portable artificial kidney that helps people remove waste and fluids through more frequent, prolonged, or continuous dialysis sessions on the go without interrupting their daily activities. This could improve the patient's health while reducing the impact of treatment on quality of life. Hence, the portable artificial kidney is likely to see rapid adoption, which drives the growth of the market.
Developing countries in Africa and the Middle East, representing a large population of End-Stage Renal Diseases, do not have a well-established system of full reimbursement and insurance coverage for dialysis. Reimbursement is essential for the greater acceptability of dialysis due to the high cost of treatment. As a result, most patients in emerging countries drop out of treatment halfway or do not have access to treatment due to financial constraints. This is a key factor that is expected to hamper the hemodialysis and peritoneal dialysis market growth. In developing African countries, only 20% of patients receive dialysis treatment.
The preference for home therapies is increasing due to their flexible treatment options, reduced costs, and fear of continued coronavirus infection. There is ample evidence that COVID-19 causes serious immunity problems in the most severe patients. Studies also suggest that infection with COVID-19 causes acute kidney injury (AKI). People on dialysis have to visit clinics or hospitals 2-3 times a week, where there are concerns that patients may be infected with the coronavirus. The need to diagnose, treat and monitor patients without human contact has increased to contain the spread of COVID-19, resulting in a greater preference for home dialysis among patients.
COVID-19 can affect the global economy in three main ways: directly affecting production and demand, disrupting the supply chain and market, and its financial impact on businesses and financial markets.
This research report on the MEA Dialysis Equipment Market has been segmented and sub-segmented into the following categories:
By End User:
Geographically, the market for portable dialysis machines is estimated to be growing slowly in South Africa. The country is an upper-middle-income country and is experiencing development in the health sector; however, countries like Saudi Arabia, United Arab Emirates, Kuwait, and Israel have better-expected growth for the forecasted period.
The South African hemodialysis and peritoneal dialysis market size are expected to reach USD 858 million by 2026. The increasing incidence of end-stage renal disease (ESRD) is expected to drive the market at a CAGR of 7, 5% over the forecasted period.
KEY MARKET PLAYERS:
A few of the companies operating in the Middle East & Africa dialysis equipment market profiled in the report are Fresenius Medical Care AG & Co., Gambro AB, Baxter International Inc., Nipro Inc., ALL-MED Medical GmbH, Asahi Kasei Corporation, and others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Hemodialysis Equipment
188.8.131.52 Hemodialysis Machines
184.108.40.206 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
220.127.116.11 Continuous Cycling Peritoneal Dialysis
18.104.22.168 Continuous Ambulatory Peritoneal Dialysis
22.214.171.124 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.3.2 In-Center Dialysis
5.3.3 Homecare Dialysis
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
184.108.40.206 By End User
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
22.214.171.124 By End User
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
184.108.40.206 By End User
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures